A Survey of State Hospital Admissions From an Area Served by a Mental Health Center

1975 ◽  
Vol 26 (9) ◽  
pp. 593-596
Author(s):  
David K. Kentsmith ◽  
W. Walter Menninger ◽  
Lolafaye Coyne
2009 ◽  
Vol 10 (2) ◽  
pp. 38-60
Author(s):  
Catherine Heard

In 1948, a schizophrenic woman admitted to the Eastern State Hospital in Knoxville, Tennessee, began shredding rags into coloured thread and begging hospital staff to give her a sewing needle. In the space of seven years, she created several garments, densely embroidered with images and glossolalic text. Ward notes dismissively summarized, “She sews without purpose…is non-productive”. In 1955 she was medicated with the newly developed drug, chlorpromazine, and stopped sewing. Over the years, most of the works were lost –– along with the medical records of their creator, who is known by the pseudonym, “Myrllen”. Today, only two artifacts remain: a scarf, which hangs in Lakeshore Mental Health Center in Knoxville; and a coat, preserved in the Tennessee State Museum. My research is the first academic study of these artifacts, which are virtually unknown outside of Tennessee and Maryland.


2011 ◽  
Vol 45 (1) ◽  
pp. 14-23 ◽  
Author(s):  
Claudiane Salles Daltio ◽  
Jair Jesus Mari ◽  
Marcos Bosi Ferraz

OBJECTIVE: To assess direct medical costs associated with schizophrenia relapses in mental health services. METHODS: The study was conducted in three health facilities in the city of São Paulo: a public state hospital; a Brazilian National Health System (SUS)-contracted hospital; and a community mental health center. Medical records of 90 patients with schizophrenia who received care in 2006 were reviewed. Information on inpatient expenditures was collected and used for cost estimates. RESULTS: Mean direct medical cost of schizophrenia relapses per patient was US$ 4,083.50 (R$ 8,167.58) in the public state hospital; US$ 2,302.76 (R$ 4,605.46) in the community mental health center; and US$ 1,198.50 (R$ 2,397.74) in the SUS-affiliated hospital. The main component was daily inpatient room rates (87% - 98%). Medication costs varied depending on the use of typical or atypical antipsychotic drugs. Atypical antipsychotic drugs were more often used in the community mental health center. CONCLUSIONS: Costs associated with schizophrenia relapses support investments in antipsychotic drugs and strategies to reduce disease relapse and the need for mental health inpatient services. Treating patients in a community mental health center was associated with medium costs and added the benefit of not depriving these patients from family life.


Sign in / Sign up

Export Citation Format

Share Document